Vaginal misoprostol effective for early pregnancy failure

Article

Treatment of first-trimester pregnancy failure with vaginal misoprostol is effective, well-tolerated, and acceptable to most women, according to a randomized trial.

Treatment of first-trimester pregnancy failure with vaginal misoprostol is effective, well-tolerated, and acceptable to most women, according to a randomized trial.

Over 650 women with early pregnancy failure due to anembryonic gestation, embryonic or fetal death, or incomplete or inevitable spontaneous abortion received either 800 μg of vaginal misoprostol or vacuum aspiration. Researchers administered a second dose of misoprostol on day 3 if expulsion was incomplete and performed vacuum aspiration on day 8 if expulsion was still incomplete.

Of almost 500 women receiving misoprostol, 71% had complete expulsion by day 3 and 84% by day 8. Treatment failed in 16% of the misoprostol group and in 3% of the surgical group. Treatment failure was defined as surgical treatment for the misoprostol group and repeat aspiration for the vacuum group within 30 days of initial treatment.

Zhang J, Gilles JM, Barnhart K, et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005;353:761-769.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.